Case Western researchers present new findings for glioblastoma
- Posted: April 5, 2012
Physician-scientists from University Hospitals (UH), Case Medical Center's Seidman Cancer Center and Case Western Reserve University School of Medicine presented new research findings this week at the Annual Meeting of the American Association for Cancer Research (AACR) in Chicago. One study sought to identify protein biomarkers that can help physicians determine which patients may benefit from standard treatment for GBM.
Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.